Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company Pharmaceutical Investing
Bristol Myers Squibb Announces Topline Results Showing Treatment with Orencia Improved Survival in People Hospitalized with COVID-19 Pharmaceutical Investing
Gilead Sciences Appoints Stacey Ma, PhD as Executive Vice President, Pharmaceutical Development and Manufacturing Pharmaceutical Investing
Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs Pharmaceutical Investing
Potent Ventures Inc. Announces Commencement of Trading of Common Shares Under the Symbol "GUMY" and Formal Change of Name Biotech Investing
AbbVie Presents Positive Results from Phase 3 SELECT-AXIS 2 Trials of Upadacitinib in Patients with Axial Spondyloarthritis at EULAR 2022 Pharmaceutical Investing
